Literature DB >> 27599517

5-Lipoxygenase inhibitor zileuton inhibits Ca(2+)-responses induced by glutoxim and molixan in macrophages.

Z I Krutetskaya1, L S Milenina2, A A Naumova2, V G Antonov2, A D Nozdrachev2.   

Abstract

Using Fura-2AM microfluorimetry, we have shown for the first time that 5-lipoxygenase specific inhibitor antiasthmatic agent zileuton significantly inhibits Ca(2+)-responses induced by glutoxim and molixan in macrophages. The results support 5-lipoxygenase involvement in the effect of glutoxim and molixan on intracellular Ca(2+) concentration in macrophages and indicate the inadvisability of a combined use of drugs glutoxim and molixan and antiasthmatic agent zileuton.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27599517     DOI: 10.1134/S1607672916040177

Source DB:  PubMed          Journal:  Dokl Biochem Biophys        ISSN: 1607-6729            Impact factor:   0.788


  13 in total

1.  Zileuton, a new efficient and safe systemic anti-acne drug.

Authors:  Christos C Zouboulis
Journal:  Dermatoendocrinol       Date:  2009-05

2.  A new generation of Ca2+ indicators with greatly improved fluorescence properties.

Authors:  G Grynkiewicz; M Poenie; R Y Tsien
Journal:  J Biol Chem       Date:  1985-03-25       Impact factor: 5.157

3.  Phospholipase A2 inhibitors modulate the effects of glutoxim and molixan on the intracellular Ca(2+) level in macrophages.

Authors:  Z I Krutetskaya; L S Milenina; A A Naumova; V G Antonov; A D Nozdrachev
Journal:  Dokl Biochem Biophys       Date:  2016-01-05       Impact factor: 0.788

4.  Calcium influx factor from cytochrome P-450 metabolism and secretion-like coupling mechanisms for capacitative calcium entry in corneal endothelial cells.

Authors:  Qiang Xie; Yan Zhang; Changbin Zhai; Joseph A Bonanno
Journal:  J Biol Chem       Date:  2002-02-26       Impact factor: 5.157

Review 5.  Eicosanoids in inflammation: biosynthesis, pharmacology, and therapeutic frontiers.

Authors:  Subhash P Khanapure; David S Garvey; David R Janero; L Gordon Letts
Journal:  Curr Top Med Chem       Date:  2007       Impact factor: 3.295

Review 6.  Zileuton: the first 5-lipoxygenase inhibitor for the treatment of asthma.

Authors:  S E Wenzel; A K Kamada
Journal:  Ann Pharmacother       Date:  1996 Jul-Aug       Impact factor: 3.154

7.  [THE EFFECT OF EPOXYGENASE INHIBITORS ON Ca(2+)-RESPONSES INDUCED BY GLUTOXIM AND MOLIXAN IN MACROPHAGES].

Authors:  L S Milenina; Z I Krutetskaya; A A Naumova; S N Butov; N I Krutetskaya; V G Antonov
Journal:  Tsitologiia       Date:  2015

Review 8.  Zileuton: clinical implications of 5-Lipoxygenase inhibition in severe airway disease.

Authors:  W Berger; M T M De Chandt; C B Cairns
Journal:  Int J Clin Pract       Date:  2007-04       Impact factor: 2.503

9.  Targeting Ca2+ release-activated Ca2+ channel channels and leukotriene receptors provides a novel combination strategy for treating nasal polyposis.

Authors:  Joseph Di Capite; Charmaine Nelson; Grant Bates; Anant B Parekh
Journal:  J Allergy Clin Immunol       Date:  2009-11       Impact factor: 10.793

10.  Intercellular Ca2+ wave propagation involving positive feedback between CRAC channels and cysteinyl leukotrienes.

Authors:  Joseph Di Capite; Anna Shirley; Charmaine Nelson; Grant Bates; Anant B Parekh
Journal:  FASEB J       Date:  2008-10-31       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.